Brown Advisory’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.1M Sell
1,518,018
-372,868
-20% -$6.51M 0.04% 297
2025
Q4
$33.6M Sell
1,890,886
-3,819
-0.2% -$66.9K 0.05% 250
2025
Q3
$35.1M Buy
1,894,705
+270,004
+17% +$5.56M 0.05% 249
2025
Q2
$34.9M Sell
1,624,701
-4,046
-0.2% -$87.5K 0.05% 244
2025
Q1
$40.1M Buy
1,628,747
+94,719
+6% +$2.34M 0.06% 213
2024
Q4
$35.6M Sell
1,534,028
-63,375
-4% -$1.58M 0.05% 260
2024
Q3
$43.3M Sell
1,597,403
-19,443
-1% -$589K 0.05% 234
2024
Q2
$46.5M Sell
1,616,846
-31,592
-2% -$969K 0.06% 216
2024
Q1
$48.1M Buy
1,648,438
+19,659
+1% +$550K 0.06% 215
2023
Q4
$53M Buy
1,628,779
+25,337
+2% +$735K 0.07% 192
2023
Q3
$51.3M Sell
1,603,442
-1,331
-0.1% -$51.3K 0.08% 184
2023
Q2
$70.4M Sell
1,604,773
-7,749
-0.5% -$357K 0.11% 157
2023
Q1
$71.4M Buy
1,612,522
+26,668
+2% +$1.18M 0.12% 156
2022
Q4
$63M Buy
1,585,854
+18,238
+1% +$760K 0.12% 158
2022
Q3
$72.3M Buy
1,567,616
+7,059
+0.5% +$346K 0.14% 134
2022
Q2
$67.3M Buy
1,560,557
+316,487
+25% +$14.5M 0.13% 147
2022
Q1
$67.2M Buy
1,244,070
+175,506
+16% +$8.97M 0.1% 165
2021
Q4
$64M Sell
1,068,564
-4,171
-0.4% -$260K 0.08% 185
2021
Q3
$70.3M Sell
1,072,735
-194,635
-15% -$12.6M 0.1% 156
2021
Q2
$80.1M Buy
1,267,370
+111,604
+10% +$6.41M 0.12% 147
2021
Q1
$56.3M Buy
1,155,766
+26,987
+2% +$1.3M 0.1% 163
2020
Q4
$46.6M Buy
1,128,779
+17,794
+2% +$816K 0.08% 169
2020
Q3
$51M Buy
1,110,985
+199,641
+22% +$9.26M 0.11% 138
2020
Q2
$39.9M Buy
911,344
+257,050
+39% +$11.6M 0.09% 151
2020
Q1
$25.9M Buy
654,294
+483,925
+284% +$21.7M 0.08% 178
2019
Q4
$8.01M Buy
170,369
+72,186
+74% +$2.8M 0.02% 355
2019
Q3
$3.46M Buy
+98,183
New +$3.4M 0.01% 450
2019
Q2
Sell
-4,556
Closed -$202K 1152
2019
Q1
$202K Buy
+4,556
New +$173K ﹤0.01% 1249

Other funds holding KIDS

Brown Advisory's KIDS Position: Q1 2026 in Review

Brown Advisory reduced its OrthoPediatrics (KIDS) stake by 20% in Q1 2026, selling an estimated $6.51M and leaving 1,518,018 shares worth $24.1M. The position accounts for 0.04% of the portfolio, ranked #297.

Brown Advisory first reported a position in KIDS in Q1 2019 and has held it in 28 quarters since. The position peaked at $80.1M in Q2 2021. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

  • Brown Advisory held 1,518,018 shares of OrthoPediatrics worth $24.1M as of Q1 2026.
  • Brown Advisory sold 372,868 OrthoPediatrics shares in Q1 2026, an estimated $6.51M.
  • OrthoPediatrics made up 0.04% of Brown Advisory's portfolio in Q1 2026, its #297 holding.
  • Brown Advisory first reported a position in OrthoPediatrics in Q1 2019 and has held it in 28 quarters since.
  • Brown Advisory's OrthoPediatrics position peaked at $80.1M in Q2 2021.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.